We have shown that patients with various ADCY5 gene mutations can present with a wider variety of movement disorder syndromes, similar to what was previously reported.16, 17 We describe novel clinical features associated with ADCY5‐related dyskinesia that distinguish this disorder from other hyperkinetic movement disorders. The gene discussed is ADCY5; the disease is drug-induced dyskinesia.